Profits didn't drive flu vaccine decisions: US officials
This article was originally published in Scrip
Executive Summary
Profits did not drive the decision not to have manufacturers do a mid-course shift when it was recognized early on the H3N2 influenza strain had "drifted," and therefore would not match the vaccine that was produced for the Northern Hemisphere's 2014-15 season, US officials insisted during a Capitol Hill hearing on 3 February.